Investigation of polymer drug conjugates for pancreatic cancer

QR Code

Investigation of polymer drug conjugates for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal forms of cancer with a 10-year survival rate of <1 %. Although considerable advancement has been made in understanding the biology of the disease, most patients presenting with locally advanced or metastatic disease have an extremel...

Full description

Bibliographic Details
Main Author:	Anane-Adjei, Akosua Bema
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2020
Online Access:	https://eprints.nottingham.ac.uk/59893/

Similar Items

Antibody drug conjugate in cancer therapy
by: Bakhtiar, M. Taher
Published: (2019)

Investigation of Novel Biomarkers for Pancreatic Cancer
by: Emmanouilidi, Aikaterini
Published: (2019)

Investigating therapeutic intervention strategies in pancreatic cancer
by: Malhotra, Pratibha
Published: (2023)

Mesoporous silica nanoparticles as anticancer drug carriers in pancreatic cancer treatment
by: Chung, Shei Li
Published: (2025)

Hypermutation In Pancreatic Cancer
by: Humphris, J., et al.
Published: (2017)

Synthesis and properties of a biodegradable polymer-drug conjugate: Methotrexate-poly(glycerol adipate)
by: Suksiriworapong, Jiraphong, et al.
Published: (2018)

Preoperative drainage in pancreatic cancer
by: Kennedy, Eugene P, et al.
Published: (2010)

Diet and pancreatic cancer prevention
by: Casari, I., et al.
Published: (2015)

A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment
by: Jinling, Joanna Lee, et al.
Published: (2017)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006)

Targeting thioredoxin reductase in pancreatic cancer
by: Alhadyan, Khaled
Published: (2019)

Network formation mechanisms in conjugated microporous polymers
by: Laybourn, Andrea, et al.
Published: (2014)

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)

Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)

Association between family cancer history and risk of pancreatic cancer.
by: Schulte, A., et al.
Published: (2016)

Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: Investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile
by: Siddalingappa, B., et al.
Published: (2015)

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
by: Abrams, S., et al.
Published: (2018)

Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case–control study
by: Kho, P., et al.
Published: (2016)

Development of Thermo-responsive materials for pancreatic cancer management
by: ElSherbeny, Amr Moustafa Said Moustafa
Published: (2024)

Mechanisms of oral bacterial virulence factors in pancreatic cancer
by: Sun, Zhong, et al.
Published: (2019)

Genomic analyses identify molecular subtypes of pancreatic cancer
by: Bailey, P., et al.
Published: (2016)

Whole genomes redefine the mutational landscape of pancreatic cancer
by: Waddell, N., et al.
Published: (2015)

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

Reactive Conjugated Polymers: Synthesis, Modification, and Electrochemical Properties of Polypentafluorophenylacetylene (Co)Polymers
by: Bhebhe, M., et al.
Published: (2016)

Polyamine sulfur conjugates: a paradigmn for selective drug delivery to cancer cells via polyamine transport system
by: Abdul Ghani, Radiah, et al.
Published: (2018)

Novel functionalized polymers for nanoparticle formulations with anti cancer drugs
by: Puri, Sanyogitta
Published: (2007)

The role of G protein-coupled receptor 35 in pancreatic cancer
by: Kim, Minkyoung
Published: (2020)

Premalignant pancreatic cancer diagnosis using proteomic pattern analysis
by: Htike@Muhammad Yusof, Zaw Zaw
Published: (2015)

Premalignant pancreatic cancer diagnosis using proteomic pattern analysis
by: Htike@Muhammad Yusof, Zaw Zaw
Published: (2014)

Emerging role of the KRAS-PDK1 axis in pancreatic cancer
by: Ferro, R., et al.
Published: (2014)

Returning individual research results for genome sequences of pancreatic cancer
by: Johns, A., et al.
Published: (2014)

Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer
by: Fritschi, Lin, et al.
Published: (2015)

Surgical Management in Patients With Pancreatic Cancer: a Queensland Perspective
by: Wylie, N., et al.
Published: (2013)

Drug release and kinetic study of tamoxifen citrate conjugated with magnetite nanoparticle for drug delivery application
by: Albert, Emmellie Laura, et al.
Published: (2018)

Increasing drug retention in lung tissue through conjugation with polyethylene-glycol
by: Bayard, Fabrice J.C.
Published: (2013)

A putrescine–anthracene conjugate : a paradigm for selective drug delivery
by: Palmer, Andrew, et al.
Published: (2009)

Synthesis of a biocompatible nanoporous carbon and its conjugation with florescent dye for cellular imaging and targeted drug delivery to cancer cells
by: Yallappa, S., et al.
Published: (2018)

Pancreatic injuries
by: Hassan, Radhiana
Published: (2018)

Identification and molecular analysis of pancreatic cancer-derived small extracellular vesicles
by: Panda, Arunima
Published: (2024)